FSSNX
Price
$27.92
Change
-$1.28 (-4.38%)
Updated
Dec 18 closing price
IJSTX
Price
$15.65
Change
-$0.67 (-4.11%)
Updated
Dec 18 closing price
Ad is loading...

FSSNX vs IJSTX

Header iconFSSNX vs IJSTX Comparison
Open Charts FSSNX vs IJSTXBanner chart's image
Fidelity Small Cap Index
Price$27.92
Change-$1.28 (-4.38%)
VolumeN/A
CapitalizationN/A
VY® JPMorgan Small Cap Core Equity S2
Price$15.65
Change-$0.67 (-4.11%)
VolumeN/A
CapitalizationN/A
FSSNX vs IJSTX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSSNX vs. IJSTX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSSNX is a Hold and IJSTX is a Hold.

FUNDAMENTALS
Fundamentals
FSSNX has more cash in the bank: 29.5B vs. IJSTX (445M). FSSNX pays higher dividends than IJSTX: FSSNX (1.36) vs IJSTX (0.00). FSSNX was incepted earlier than IJSTX: FSSNX (13 years) vs IJSTX (22 years). FSSNX (0) and IJSTX (0) have matching initial minimum investment requirements. FSSNX annual gain was more profitable for investors over the last year : 19.49 vs. IJSTX (17.49). FSSNX return over 5 years is better than : 46.38 vs. IJSTX (4.14).
FSSNXIJSTXFSSNX / IJSTX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years22 years-
Gain YTD16.77015.413109%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets29.5B445M6,629%
Annual Yield % from dividends1.360.00-
Returns for 1 year19.4917.49111%
Returns for 3 years12.65-17.10-74%
Returns for 5 years46.384.141,120%
Returns for 10 years90.42-17.96-503%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AENT6.250.42
+7.20%
Alliance Entertainment Holding Corp
IDYA26.330.28
+1.07%
IDEAYA Biosciences
BIO337.85-5.10
-1.49%
Bio-Rad Laboratories IncClass A
BFST27.02-0.76
-2.74%
Business First Bancshares
PCSA1.01-0.03
-2.88%
Processa Pharmaceuticals